Research ArticleOriginal Article
Open Access
The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study
Abdullah M. Alguwaihes, Amani Alhozali, Moataz M. Yahia, Tarek Abdel-Nabi, Mohamed Hassan Hatahet, Nader I. Albalkhi and Saud Al Sifri
Saudi Medical Journal January 2023, 44 (1) 57-66; DOI: https://doi.org/10.15537/smj.2023.44.1.20220402
Abdullah M. Alguwaihes
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
Amani Alhozali
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
Moataz M. Yahia
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
Tarek Abdel-Nabi
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
Mohamed Hassan Hatahet
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
Nader I. Albalkhi
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.
Saud Al Sifri
From the Department of Internal Medicine (Alguwaihes), King Saud University, from the Department of Internal Medicine (Alguwaihes), King Saud University Medical City, from the Department of Medical Affairs (Yahia, Abdel-Nabi), Novo Nordisk, from the Department of Internal Medicine (Albalkhi), Specialized Medical Centre Hospital, Riyadh, from the Department of Internal Medicine (Alhozali), King Abdulaziz University Hospital, Jeddah, from the Department of Internal Medicine (Hatahet), King Abdulaziz Hospital for National Guard, Al Ahsa, and from the Department of Internal Medicine (Al Sifri), Al Hada Military Hospital, Taif, Kingdom of Saudi Arabia.

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study
Abdullah M. Alguwaihes, Amani Alhozali, Moataz M. Yahia, Tarek Abdel-Nabi, Mohamed Hassan Hatahet, Nader I. Albalkhi, Saud Al Sifri
Saudi Medical Journal Jan 2023, 44 (1) 57-66; DOI: 10.15537/smj.2023.44.1.20220402
The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study
Abdullah M. Alguwaihes, Amani Alhozali, Moataz M. Yahia, Tarek Abdel-Nabi, Mohamed Hassan Hatahet, Nader I. Albalkhi, Saud Al Sifri
Saudi Medical Journal Jan 2023, 44 (1) 57-66; DOI: 10.15537/smj.2023.44.1.20220402
Jump to section
- Article
- Abstract
- Methods
- Results
- Discussion
- Acknowledgment
- Appendix 1 - List of independent Ethics Committees/Institutional Review Boards.
- Appendix 2 - Definition of atherosclerotic cardiovascular disease and cardiovascular disease subtypes in the CAPTURE study.
- Appendix 3 - Prevalence of cardiovascular disease subtypes among CAPTURE study participants in Saudi Arabia by care setting.
- Footnotes
- References
- Figures & Data
- eLetters
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.